Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Pharma Sales to Grow Beyond $1 Trillion | ||
By: PR Newswire Association LLC. - 04 Aug 2015 | Back to overview list |
|
PHILADELPHIA, Aug. 4, 2015 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals announced the release of the 2015 CMR Pharmaceutical R&D Factbook, the biopharmaceutical industry's leading resource of global R&D trends. Despite concerns around declines in R&D, the analysis identifies a surge in global sales with 2014's $1 trillion milestone and forecasts sales to reach $1.3 trillion by 2018. It also reveals a positive shift in new molecular entities (NMEs) with 46 launches in 2014; the highest in over a decade. The study underscores a promising industry outlook with increases in sales and NME launches and with shifting trends in R&D pipeline volume and therapeutic areas as evidenced by these other key findings:
Since 2003, the CMR Pharmaceutical R&D Factbook has been built in collaboration with leading global pharmaceutical companies to assess productivity and to provide insights to strengthen planning and the effectiveness of R&D. It is based on proprietary, primary sources, competitive intelligence, and public sources covering key trends across the landscape, including R&D pipeline volume, success rates, cycle times, regional comparisons, therapeutic areas, and generics. "This is an extraordinary year for pharma," said Basil Moftah, president, Thomson Reuters IP & Science. "Not only do the critical insights provided by the Factbook challenge negative perceptions, but it demonstrates this industry's continued commitment to creating and employing innovative solutions to tackle its largest hurdles." Learn more about the CMR Factbook. Thomson Reuters CONTACT Jen Breen David Russell SOURCE Thomson Reuters |
||
|
||
Copyright 2015 PR Newswire Association LLC. | Back to overview list |